For: | Zhang YW. Promise and challenges on the horizon of MET-targeted cancer therapeutics. World J Biol Chem 2015; 6(2): 16-27 [PMID: 26009700 DOI: 10.4331/wjbc.v6.i2.16] |
---|---|
URL: | https://www.wjgnet.com/1949-8454/full/v6/i2/16.htm |
Number | Citing Articles |
1 |
Olga Kondrashova, Clare J. Love, Sebastian Lunke, Arthur L. Hsu, Paul M. Waring, Graham R. Taylor, Alvaro Galli. High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq. PLOS ONE 2015; 10(11): e0143006 doi: 10.1371/journal.pone.0143006
|
2 |
J. Lee, P. Tran, S.J. Klempner. Targeting the MET Pathway in Gastric and Oesophageal Cancers: Refining the Optimal Approach. Clinical Oncology 2016; 28(8): e35 doi: 10.1016/j.clon.2016.01.009
|
3 |
Jiali Zhang, Zuo Wang, Siwei Zhang, Yanxun Chen, Xuexue Xiong, Xiaojuan Li, Nicholas K. Tonks, Gaofeng Fan. Spatial regulation of signaling by the coordinated action of the protein tyrosine kinases MET and FER. Cellular Signalling 2018; 50: 100 doi: 10.1016/j.cellsig.2018.06.006
|
4 |
Wei Meng, Tao Chen. Association between the HGF/c‑MET signaling pathway and tumorigenesis, progression and prognosis of hepatocellular carcinoma (Review). Oncology Reports 2021; 46(3) doi: 10.3892/or.2021.8142
|
5 |
Ning Yi Yap, Retnagowri Rajandram, Keng Lim Ng, Jayalakshmi Pailoor, Ahmad Fadzli, Glenda Carolyn Gobe. Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/476508
|
6 |
Maria Trovato, Alfredo Campennì, Salvatore Giovinazzo, Massimiliano Siracusa, Rosaria Maddalena Ruggeri. Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target. Biomarker Insights 2017; 12: 117727191770112 doi: 10.1177/1177271917701126
|